On this episode of Cerevel Drug Hunters, Dr. John Renger interviews Dr. Srinivas Chakilam, Vice President, Drug Metabolism and Pharmacokinetics (DMPK). We get an inside look into what Srinivas and his team do at Cerevel to uncover and understand molecule properties from the research stage all the way to filing NDAs (New Drug Applications). They help to unravel how the drug is metabolized and what it does to the body to glean efficacy information.
On this episode of Cerevel Drug Hunters, Dr. John Renger interviews Dr. Srinivas Chakilam, Vice President, Drug Metabolism and Pharmacokinetics (DMPK). We get an inside look into what Srinivas and his team do at Cerevel to uncover and understand molecule properties from the research stage all the way to filing NDAs (New Drug Applications). They help to unravel how the drug is metabolized and what it does to the body to glean efficacy information.